[1] 蒋仲元,赵德明.银屑病.见:赵辨,主编.临床皮肤病学.第2版.南京:江苏科学技术出版社,1989.663-677. [2] Economidou J,Barkis J,Demetriou Z,et al.Effects of cyclosporin A on immune activation markers in patients withactivepsoriasis.Dermatology,1999,199:144-148. [3] Ellis CN,Barker JNWN.Psoriasis,a view for the year 2000.Curr Probl Dermatol,2000,12:45-50. [4] Schlaak JF,Buslau M,Jochum W,et al.T cells involved in psoriasis vulgaris belong to the Th1 subset.JInvestDermatol,1994,102:145-149. [5] Miossec P,van den Berg W.Th1/Th2 cytokine balance inarthritis.ArthritisRheum,1997,40:2105-2115. [6] Owen CM,Harrison PV.Successful treatment of severe psoriasis with basiliximab,an interleukin-2 receptor monoclonal antibody.ClinExpDermatol,2000,25:195-197. [7] Sauder DN,Dytoc MT.Cytokines.Curr Probl Dermatol,1997,9:5-30. [8] Barner M,Bos JD,Kapsenberg ML,et al.Effect of calcitriol on the production of T-cell-derived cytokines in psoriasis.Br J Dermatol,1997,136:536-541. [9] de Rie MA.Interleukin 12andpsoriasis.Dermatology,1999,199:101. |